GTBP Projected Dividend Yield
GT Biopharma Inc ( NASDAQ : GTBP )GT Biopharma is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE®) fusion protein immune cell engager technology platform. Co.'s TriKE® platform generate proprietary therapeutics designed to harness and improve the cancer killing abilities of a patient's own natural killer cells. Co. is using its TriKE® platform for immuno-oncology products that can treat a range of hematologic malignancies and solid tumors, as well as to develop therapeutics for the treatment of infectious disease such as for the treatment of patients infected by the human immunodeficiency virus. 20 YEAR PERFORMANCE RESULTS |
GTBP Dividend History Detail GTBP Dividend News GTBP Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |